- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05711602
The Physical and Mental Health of People With Type II Diabetes Mellitus.
March 16, 2025 updated by: Agustín Aibar Almazán, University of Jaén
Influence of the Pilates Method on the Physical and Mental Health of People With Type II Diabetes Mellitus.
To analyze the effects of a Pilates exercise program on physical and mental health in people with type II diabetes mellitus.
Study Overview
Detailed Description
This is a randomized clinical trial of single-blind with 2 arms (Control group and experimental group), in which a pre-treatment-postest design has been used.
The study will define two groups:
- A control group (CG) that will not be submitted to treatment, which will be evaluated in the pre and post phase of the study. Participants assigned to this group will receive general advice on the positive effects of regular physical activity and will be given a guide to recommendations for promoting physical activity.
- An experimental group (GE) that after an initial evaluation will undergo a physical training program based on Pilates exercises.
Once the intervention is finished, it will be submitted to a final evaluation to see if there is a difference or not with the results obtained at the beginning.
Study Type
Interventional
Enrollment (Actual)
104
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Jaén, Spain, 23004
- U.E.D. Virgen de la Capilla
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
60 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Description
Inclusion Criteria:
- Diagnosis of type 2 diabetes mellitus
- Not participating in an exercise program
- That they were able to carry out the different selected questionnaires.
Exclusion Criteria:
- Contraindications for performing physical tests
- Illnesses that limit static and dynamic balance and physical activity
- Central or peripheral vestibular or nervous disorders.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Triple
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Pilates group
This group receives physical training based on pilates exercises
|
raining based on a basic level Pilates exercise program will be as follows: A duration of weeks with a frequency of 2 sessions a week and with a duration of 55 minutes each.
The exercises to be performed will be divided into three distinct phases: warm-up, lasting 15 minutes; Main part with a duration of 30 minutes and the return to calm, based mostly on stretching and with a duration of 10 minutes.
The repetitions of the exercises will be between 5 and 10 according to the difficulty.
|
|
No Intervention: No intervention group
This group does not receive any treatment
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
BMI (Body Mass Index)
Time Frame: Up to twelve weeks
|
Is calculated from the formula, Weight (kg) / Height2 (m2), whose unit is kg/m2.
It is a rough indicator of total body fat.
|
Up to twelve weeks
|
|
Dynamometer
Time Frame: Up to twelve weeks
|
Dynamometer will be employed to assess hand grip stregth.
|
Up to twelve weeks
|
|
TUG (Timed Up and Go test)
Time Frame: Up to twelve weeks
|
Is a simple test used to assess a person's mobility and physical function
|
Up to twelve weeks
|
|
BBS (the Berg Balance Scale)
Time Frame: Up to twelve weeks
|
Used to measure balance
|
Up to twelve weeks
|
|
Chair sit and reach test
Time Frame: Up to twelve weeks
|
To test low back and hamstring flexibility.
|
Up to twelve weeks
|
|
Back scratch test
Time Frame: Up to twelve weeks
|
To measure general shoulder range of motion.
|
Up to twelve weeks
|
|
Blood Glucose Concentration
Time Frame: Up to twelve weeks
|
Capillary blood glucose monitoring is the primary tool for monitoring blood glucose levels at any time of day.
It involves a small fingertip prick to check blood sugar levels at a specific time of day.
This procedure requires a pen containing a fine needle or lancet, test strips, and a glucose meter (glucometer).
Reference values vary depending on the time of sample collection: preprandial 80-130 mg/dL and postprandial <180 mg/dL.
In Spain, this measurement is performed among older adults with type 2 diabetes mellitus.
|
Up to twelve weeks
|
|
Height
Time Frame: Up to twelve weeks
|
The distance between the lowest and highest points of a person standing upright.
|
Up to twelve weeks
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
January 9, 2024
Primary Completion (Actual)
January 20, 2024
Study Completion (Actual)
April 21, 2024
Study Registration Dates
First Submitted
January 21, 2023
First Submitted That Met QC Criteria
January 31, 2023
First Posted (Actual)
February 3, 2023
Study Record Updates
Last Update Posted (Actual)
March 25, 2025
Last Update Submitted That Met QC Criteria
March 16, 2025
Last Verified
March 1, 2025
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- University_of_Jaén
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.